Martin Renz

Martin Renz

Auto-generated profile, based on publicly available information

Martin Renz

Department of Neuroradiology, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Radiology
Verified
Journal Article
Closed access
SFSarah C. Foreman
Sarah C. Foreman
DSDavid Schinz
David Schinz
MHMalek El Husseini
Malek El Husseini
SGSophia Samira Goller
Sophia Samira Goller
JWJürgen Weißinger
Jürgen Weißinger
AGAlexandra S. Gersing
Alexandra S. Gersing
Background Differentiating between benign and malignant vertebral fractures poses diagnostic challenges. Purpose To investigate the reliability of CT-based deep learning models to differentiate between benign and malignant vertebral fractures. Materials and Methods CT scans acquired in patients with benign or malignant vertebral fractures from June 2005 to December 2022 at two university hospitals were retrospectively identified based on a composite reference standard that included histopathologic and radiologic information. An internal test set was randomly selected, and an external test set was obtained from an additional hospital. Models used a three-dimensional U-Net encoder-classifier architecture and applied data augmentation during training. Performance was evaluated using the area under the receiver operating characteristic curve (AUC) and compared with that of two residents and one fellowship-trained radiologist using the DeLong test. Results The training set included 381 patients (mean age, 69.9 years ± 11.4 [SD]; 193 male) with 1307 vertebrae (378 benign fractures, 447 malignant fractures, 482 malignant lesions). Internal and external test sets included 86 (mean age, 66.9 years ± 12; 45 male) and 65 (mean age, 68.8 years ± 12.5; 39 female) patients, respectively. The better-performing model of two training approaches achieved AUCs of 0.85 (95% CI: 0.77, 0.92) in the internal and 0.75 (95% CI: 0.64, 0.85) in the external test sets. Including an uncertainty category further improved performance to AUCs of 0.91 (95% CI: 0.83, 0.97) in the internal test set and 0.76 (95% CI: 0.64, 0.88) in the external test set. The AUC values of residents were lower than that of the best-performing model in the internal test set (AUC, 0.69 [95% CI: 0.59, 0.78] and 0.71 [95% CI: 0.61, 0.80]) and external test set (AUC, 0.70 [95% CI: 0.58, 0.80] and 0.71 [95% CI: 0.60, 0.82]), with significant differences only for the internal test set (P < .001). The AUCs of the fellowship-trained radiologist were similar to those of the best-performing model (internal test set, 0.86 [95% CI: 0.78, 0.93; P = .39]; external test set, 0.71 [95% CI: 0.60, 0.82; P = .46]). Conclusion Developed models showed a high discriminatory power to differentiate between benign and malignant vertebral fractures, surpassing or matching the performance of radiology residents and matching that of a fellowship-trained radiologist. © RSNA, 2024 See also the editorial by Booz and D'Angelo in this issue.

1 May 2023 in Stroke
Verified
Journal Article
Closed access
JHJohanna Härtl
Johanna Härtl
MRMartin Renz
Martin Renz
SWSilke Wunderlich
Silke Wunderlich
BHBernhard Hemmer
Bernhard Hemmer
BHBenedikt Hofauer
Benedikt Hofauer
BIBenno Ikenberg
Benno Ikenberg
Background: Bone or cartilage anomalies with affection of brain supplying arteries are a potential structural cause for ischemic stroke. In the following, we termed this entity bony stroke. Due to rarity of their description, there is no standardized workup and therapy for bony strokes. Methods: Retrospectively, we extracted diagnostic and therapeutic workup of all patients considered to have had a bony stroke between January 2017 to March 2022 at our comprehensive care center. Results: In total, 6 patients classified as a bony stroke were identified among 4200 acute patients with ischemic stroke treated during the study period. Each patient had recurrent ischemic strokes in the dependent vascular territory before diagnosis. Diagnosis was achieved by a combination of imaging devices, including sonography, computed tomography, and magnetic resonance imaging. In addition to conventional static imaging, the application of dynamic imaging modalities with the patients’ head in rotation or reclination confirmed a vessel affection following head movements in 3 patients (50%). Treatment options were interdisciplinary assessed and included the following: conservative treatment (n=1), endovascular stenting (n=2) or occlusion (n=2), surgical removal of bone/ cartilage (n=2), and surgical bypass treatment (n=1). In follow-up (mean 11.7 months), no patient experienced further ischemia. Conclusions: As a differential diagnosis, bony strokes may be considered in patients with recurrent ischemic stroke of unknown cause in one dependent vascular territory. Interdisciplinary evaluation and treatment may eliminate risk of stroke recurrence.

1 May 2026 in Radiology
Verified
Journal Article
Closed access
SSSeverin Schramm
Severin Schramm
BGBastien Le Guellec
Bastien Le Guellec
MTMarlene Topka
Marlene Topka
MSMortimer Svec
Mortimer Svec
PBPaul Backhaus
Paul Backhaus
SKSu Hwan Kim
Su Hwan Kim
With increasing reader experience, large language model accuracy improved, whereas diagnostic gains from model assistance paradoxically diminished, highlighting the divergence between model performance and clinically relevant benefits for readers.

6 November 2024 in Brain and Spine
Verified
Journal Article
Open access
CACarolin Albrecht
Carolin Albrecht
RLRaimunde Liang
Raimunde Liang
DTDominik Trost
Dominik Trost
IHIsabel Hostettler
Isabel Hostettler
MRMartin Renz
Martin Renz
JSJulian Schwarting
Julian Schwarting
Despite targeted standard therapy, aneurysmal subarachnoid hemorrhage (aSAH) frequently leads to cerebral vasospasms (CVS) of large cerebral arteries, reduced oxygen supply of brain tissue, known as delayed cerebral ischemia (DCI), subsequent development of manifest cerebral infarction and poor neurological outcome. The primary aim was to evaluate the efficacy of endovascular spasmolysis (eSL) as a rescue therapy for delayed ischemic neurological deficits (DIND) occurring despite maximum conservative treatment, with the potential benefit of preventing permanent ischemic deficits, and thus, improving overall neurological outcomes. In our retrospective, monocentric study, we included 310 patients developing CVS during hospitalization and evaluated their clinical and radiographic outcomes. Severe vasospasm was defined by a mean velocity of >200 cm/s in transcranial Doppler ultrasound and/or occurrence of new neurological deficits, and/or decrease of at least 2 points on the Glasgow Coma Scale (GCS), respectively. 92 patients (29.7%) underwent eSL due to persistent symptoms despite conservative therapy. Among endovascularly treated patients, 86% (n = 79) improved angiographically, 71% (n = 44) of 62 patients who underwent eSL due to symptomatic deterioration improved clinically. Clinical worsening due to progressive CVS occurred in 18% of cases (n = 11). Periprocedural complications were observed in 4% (n = 4). eSL emerges as a safe and effective therapy for individuals experiencing DIND triggered by large-artery vasospasm following aSAH. The implementation of a standardized, multi-step process for detection and management, coupled with criteria for endovascular interventions, proves to be an efficient preventative approach to enhance neurological outcomes after aSAH.

3 August 2026 in Neuroradiology
Verified
Journal Article
Open access
PDF file
MGMichael Griessmair
Michael Griessmair
CMChristian Maegerlein
Christian Maegerlein
DSDominik Sepp
Dominik Sepp
DHDennis M. Hedderich
Dennis M. Hedderich
JBJannis Bodden
Jannis Bodden
TBTobias Boeckh-Behrens
Tobias Boeckh-Behrens

12 June 2026 in Brain and Spine
Verified
Journal Article
Open access
MGMichael Griessmair
Michael Griessmair
JBJannis Bodden
Jannis Bodden
DHDennis M. Hedderich
Dennis M. Hedderich
JKJan Kirschke
Jan Kirschke
CMChristian Maegerlein
Christian Maegerlein
JSJulian Schwarting
Julian Schwarting
Device-assisted endovascular treatment of ruptured aneurysms may require antiplatelet therapy, but bleeding risk is a concern. This retrospective propensity score-matched cohort study investigated whether tirofiban, including prolonged administration for ≥7 days, was associated with secondary bleeding complications. We analyzed 99 patients treated endovascularly aSAB between 2006 and 2024, including 51 patients receiving tirofiban and 48 controls selected using propensity score matching. Tirofiban patients were categorized into short-term treatment (<7 days) and prolonged treatment (≥7 days). Bleeding complications were classified using an adapted Heidelberg bleeding classification and categorized as spontaneous or surgery-associated. For the main bleeding endpoints, evaluable data were available for 42 controls, 29 patients with short-term tirofiban, and 18 patients with prolonged tirofiban. Any spontaneous secondary bleeding occurred in 6/42 controls (14%), 2/29 short-term tirofiban patients (7%; p = 0.46), and 1/18 prolonged tirofiban patients (6%; p = 0.66). Surgery-associated bleeding occurred in 13/42 controls (31%), 11/29 short-term tirofiban patients (38%; p = 0.72), and 7/18 prolonged tirofiban patients (39%; p = 0.77). Clinically relevant bleeding occurred in 2/42 controls (5%), 0/29 short-term tirofiban patients (0%; p = 0.51), and 1/18 prolonged tirofiban patients (6%; p = 1.00). Median hospital duration was 21 days in controls, 18 days in short-term, and 31 days in prolonged tirofiban patients. In this small retrospective cohort, tirofiban, including prolonged administration for ≥7 days, was not associated with a statistically significant increase in spontaneous, surgery-associated, or clinically relevant secondary bleeding. These exploratory findings require confirmation in larger prospective studies.